peripheral blood white cell counts , cell differentials , hematocrits , bone marrow white cell counts and committed granulocyte-macrophage precursors ( cfuc ) were monitored for several days following treatment with misonidazole and cyclophosphamide .
C0005953
bone marrow
C0018183
precursors